We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Escitalopram for the Treatment of Obsessive Compulsive Disorder (OCD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00116532
Recruitment Status : Completed
First Posted : June 30, 2005
Last Update Posted : April 24, 2007
Sponsor:
Collaborator:
Forest Laboratories
Information provided by:
Massachusetts General Hospital

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : No date given
  Study Completion Date : February 2007